Clinical and regulatory
News on the latest clinical and regulatory developments impacting the UK optical sector
-
Eye drops for conjunctivitis, dry eye and hay fever will no longer be routinely prescribed under NHS proposals targeting “minor, short-term” conditions
-
Ciclosporin eye drops from Santen Pharmaceuticals are now recommended for dry eye patients with severe keratitis
-
SMC issues guidance on use of the eye drops for patients in Scotland with severe keratitis
-
Allergan is recalling affected batches of its dry eye treatment due to black particles on or near the nozzle which could potentially enter the eye
-
Appraisal body calls for more information from drug company before issuing final guidance to NHS on dry eye treatment